Frequency of ocular manifestations of chronic graft versus host disease

Muhammad Aamir Arain1, Muhammad Khizar Niazi, Muhammad Dawood Khan

  • 1Armed Forces Institute of Ophthalmology, Rawalpindi. doctorarain@yahoo.com

Insights

Chronic graft versus host disease (cGVHD) significantly impacts transplant survivors, frequently causing ocular complications like dry eyes. Close ophthalmic monitoring is crucial for managing these visual health issues in cGVHD patients.

Area of Science:

  • Ophthalmology
  • Hematology
  • Transplantation Medicine

Background:

  • Increasing number of hematopoietic cell transplantation survivors leads to a rise in chronic graft versus host disease (cGVHD).
  • Ocular manifestations of cGVHD are not well-documented in certain populations.
  • This study addresses the need to explore local cGVHD ocular complications.

Purpose of the Study:

  • To determine the frequency of ocular complications in patients with cGVHD.
  • To investigate the specific types of ocular surface disorders in cGVHD patients.
  • To highlight the importance of ophthalmic surveillance in bone marrow transplant recipients.

Main Methods:

  • Evaluation of 12 diagnosed cGVHD cases between June 2008 and March 2009.
  • Detailed recording of ocular manifestations, focusing on ocular surface disorders.
  • Utilized fluorescein and rose-bengal double staining for ocular surface assessment.

Main Results:

  • High prevalence of dry eyes (75%) and meibomian gland dysfunction (58.3%) observed.
  • Other complications included acute conjunctivitis (33%), lacrimal canalicular occlusion (16.7%), and rarer conditions like cataract and corneal defects.
  • Ocular surface disorders are a significant concern in cGVHD patients.

Conclusions:

  • Dry eyes and other ocular issues are common in cGVHD.
  • Ophthalmic monitoring is essential for early detection and management of visual complications.
  • Findings emphasize the need for routine eye examinations in transplant survivors with cGVHD.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...